Active, not recruitingPhase 2NCT05180461
Emodepside Phase II Trial for Treatment of Onchocerciasis
Studying Onchocerciasis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Drugs for Neglected Diseases
- Intervention
- emodepside(drug)
- Enrollment
- 578 enrolled
- Eligibility
- 18-65 years · All sexes
- Timeline
- 2021 – 2026
Study locations (3)
- Centre de santé de référence de Kimpese, Kimpese, Bas-Congo Province, Democratic Republic of the Congo
- Hôpital général de référence de Masimanimba, Masi-Manimba, Kwilu, Democratic Republic of the Congo
- University of Health and Allied Services School of Public Health, Hohoe, Volta Region, Ghana
Collaborators
Bayer
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05180461 on ClinicalTrials.govOther trials for Onchocerciasis
Additional recruiting or active studies for the same condition.